psychedelic medicine – Talk Bio

Actionable Insights Powered by AI

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact

15 hours ago talkbio0Tagged Clearmind Medicine, Clinical Trials, governmental engagement, Mary-Elizabeth, mental health, partnerships, psychedelic medicine, regulatory advocacy, U.S.

Clearmind Medicine; Mary-Elizabeth Gifford; Chief of Global Impact; psychedelic medicine; US partnerships; governmental engagement; regulatory advocacy; biotech company; clinical trials; mental health